MAP Target of 110-130 mmHg is NOT Recommended for Acute Cerebral Infarction
For acute ischemic stroke (cerebral infarction), maintaining a MAP of 110-130 mmHg is not supported by current guidelines and may be harmful. The evidence clearly indicates that permissive hypertension is the standard approach, with blood pressure lowering only indicated in specific circumstances.
Blood Pressure Management in Acute Ischemic Stroke
When NOT Receiving Thrombolysis or Thrombectomy
Avoid aggressive blood pressure lowering unless BP exceeds 220/120 mmHg 1, 2. The 2017 ACC/AHA guidelines explicitly state that initiating antihypertensive treatment in patients with BP <220/120 mmHg who did not receive reperfusion therapy is not effective to prevent death or dependency (Class III: No Benefit, Level A) 1, 3, 4.
- If BP is ≥220/120 mmHg without other indications for acute treatment, it may be reasonable to lower MAP by 15% during the first 24 hours 1, 2
- This translates to a modest reduction, not aggressive targeting of specific ranges like 110-130 mmHg
- The ESC 2019 position document confirms: lower MAP by 15% over 1 hour when BP >220/120 mmHg 2
When Receiving Thrombolysis
Target BP <185/110 mmHg before thrombolysis and maintain <180/105 mmHg for 24 hours after 1, 3, 4, 5, 6. This is a Class I, Level B-NR recommendation.
When Receiving Thrombectomy
Maintain BP <185/110 mmHg before the procedure (Class IIa) 6. For patients who received IV thrombolytics before thrombectomy, keep systolic BP <180 mmHg 6.
Why Permissive Hypertension?
The rationale against aggressive BP lowering in acute ischemic stroke is physiologically sound:
- Cerebral autoregulation is impaired in the ischemic penumbra 1, 3, 4
- The brain requires adequate perfusion pressure to maintain collateral blood flow to salvageable tissue
- Studies show a U-shaped relationship between admission BP and outcomes, with optimal ranges around 121-200 mmHg systolic 1, 3
- Overly aggressive BP reduction can compromise cerebral perfusion pressure and worsen brain injury 7, 8
Evidence Against MAP 110-130 mmHg Target
Recent research demonstrates that high MAP trajectories after acute ischemic stroke are associated with worse outcomes 9, 10:
- High MAP trajectory (compared to low) had adjusted OR 1.92 for death and major disability 9
- Each 10 mmHg increase in MAP yielded 0.782-fold probability of favorable outcome 10
- However, this does not justify aggressive lowering to 110-130 mmHg in the acute phase
The 2025 ERC/ESICM guidelines recommend MAP >60-65 mmHg in post-cardiac arrest patients, noting that higher targets (>80 mmHg) may be needed when cerebral autoregulation is impaired 11. This context differs from acute ischemic stroke but illustrates that MAP targets must consider cerebral perfusion needs.
Common Pitfalls to Avoid
- Do not aggressively lower BP in acute ischemic stroke unless specific criteria are met (thrombolysis candidate or BP >220/120 mmHg)
- Avoid precipitous BP drops - rapid reduction can compromise penumbral perfusion 2, 7
- Do not use sodium nitroprusside - it increases intracranial pressure and worsens cerebral autoregulation 2, 7
- Preferred agents: Labetalol, nicardipine, or clevidipine for controlled BP reduction when needed 2, 6
Practical Algorithm
For acute ischemic stroke patients:
- BP <220/120 mmHg AND not receiving reperfusion therapy: Do NOT treat BP acutely
- BP ≥220/120 mmHg: Consider lowering MAP by 15% over first 24 hours
- Candidate for thrombolysis: Lower to <185/110 mmHg before treatment, maintain <180/105 mmHg for 24 hours
- Candidate for thrombectomy: Maintain <185/110 mmHg (or <180 systolic if received thrombolytics)
- After 24-48 hours in neurologically stable patients: Restart chronic antihypertensive therapy targeting <140/90 mmHg 1, 3, 4
The MAP range of 110-130 mmHg is too aggressive for acute cerebral infarction and lacks guideline support.